FY2026 Earnings
Financial report interval: 2025.06.30 - 2026.06.30
Overview: IX Biopharma(42C) the EPS is -0.0083 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EPS
-0.0083--
----
----
Revenue
ActualEstimateUnit: SGD
qf
EBIT
ActualEstimateUnit: SGD
qf
Net income
ActualEstimateUnit: SGD
qf
EPS
ActualEstimateUnit: SGD
qf